TrianglePUBLICATIONS · 12118025
Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2002 Jul 15
- First author
- Biganzoli L
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Biganzoli L
- type
- Author
- name
- Cufer T
- type
- Author
- name
- Bruning P
- type
- Author
- name
- Coleman R
- type
- Author
- name
- Duchateau L
- type
- Author
- name
- Calvert AH
- type
- Author
- name
- Gamucci T
- type
- Author
- name
- Twelves C
- type
- Author
- name
- Fargeot P
- type
- Author
- name
- Epelbaum R
- type
- Author
- name
- Lohrisch C
- type
- Author
- name
- Piccart MJ
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Biganzoli L
- type
- Author
- name
- Cufer T
- type
- Author
- name
- Bruning P
- type
- Author
- name
- Coleman R
- type
- Author
- name
- Duchateau L
- type
- Author
- name
- Calvert AH
- type
- Author
- name
- Gamucci T
- type
- Author
- name
- Twelves C
- type
- Author
- name
- Fargeot P
- type
- Author
- name
- Epelbaum R
- type
- Author
- name
- Lohrisch C
- type
- Author
- name
- Piccart MJ
- type
- Author
- bibliography ids
- nci-bib-d2ebaec1a62c6911d2a8ea53
- book metadata
- content sha256
- 0526413a96dfc3e12b6e830841c3f8935a63255e63a5e8a9564dfdb1a1a8e0e4
- document type
- citation
- dois
- 10.1200/JCO.2002.11.005
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:12118025
- immutable id
- pubmed:12118025@0526413a96dfc3e12b6e830841c3f8935a63255e63a5e8a9564dfdb1a1a8e0e4
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 14
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3114-21
- volume
- 20
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 12118025
- provenance
- batch id
- ced7794d3512d3f45188
- provider
- NCBI PubMed ESummary
- record sha256
- b8d7fb770f00ffa6f6a6513f142a68f273a8b8ca2f5cd1c92be22fc193fb133b
- response sha256
- 782bfef1f051086807ee9551561575ae64b9ca1f941a87d5259ff83e5424435e
- retrieved at
- 2026-09-09T23:45:46.208577+00:00
- publication date
- display
- 2002 Jul 15
- precision
- day
- year
- 2002
- publication types
- Clinical Trial
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial.
Preserved source evidence · Not medical advice